Carbon dots for the treatment of cancer-related anemia.
Carbon dots for the treatment of cancer-related anemia.
复制标题
DOI:
10.1097/bs9.0000000000000120
复制
发表时间:
2022-07
期刊:
影响因子:
1
通讯作者:
Ji, Peng
中科院分区:
文献类型:
--
作者:
Han, Xu;Ji, Peng
Erythropoiesis is the process in which hematopoietic stem cells (HSCs) differentiate, proliferate, and eventually form mature red blood cells. 1 The early phase of erythropoiesis involves HSC commitment to erythroid progenitors including burst-forming unit-erythroid (BFU-E) and colony forming unit-erythroid (CFU-E). This is followed by terminal erythropoiesis in which morphologically recognizable erythroblasts proliferate and differentiate to enucleated red blood cells. 2, 3 Each of these steps is coordinated by a highly complex regulatory network. Disruption of any component of this network leads to a variety of erythroid-related disorders, manifested mainly as anemia. 4Anemia is a major public health problem worldwide. 5 While primary anemia is usually caused by abnormalities in the hematopoietic system, secondary anemia can be induced by chronic diseases such as cancers. 6–9 Cancer-related anemia is a common condition with prevalence of 30% to 90% depending on cancer types and the disease stage. 10 Anemia significantly reduces the quality of life and shortens survival in cancer patients. 8